CN1969855B - 一种具有靶器官保护作用的药物组合物及其用途 - Google Patents
一种具有靶器官保护作用的药物组合物及其用途 Download PDFInfo
- Publication number
- CN1969855B CN1969855B CN2006101443568A CN200610144356A CN1969855B CN 1969855 B CN1969855 B CN 1969855B CN 2006101443568 A CN2006101443568 A CN 2006101443568A CN 200610144356 A CN200610144356 A CN 200610144356A CN 1969855 B CN1969855 B CN 1969855B
- Authority
- CN
- China
- Prior art keywords
- amlodipine
- atorvastatin
- group
- folic acid
- rat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
Description
复方种类 | 氨氯地平 | 左旋氨氯地平 | 阿托伐他汀 | 叶酸 | 亚叶酸钙 | 左旋亚叶酸钙 |
1 | 5mg | - | 10mg | 0.4mg | - | - |
2 | 5mg | - | 10mg | 1.6mg | - | - |
3 | 2.5mg | - | 80mg | 0.8mg | - | - |
4 | 10mg | - | 10mg | 0.4mg | - | - |
复方种类 | 氨氯地平 | 左旋氨氯地平 | 阿托伐他汀 | 叶酸 | 亚叶酸钙 | 左旋亚叶酸钙 |
5 | 2.5mg | - | 80mg | - | 0.5mg | - |
6 | 5mg | - | 10mg | - | 1.0mg | - |
7 | 2.5mg | - | 40mg | - | - | 0.125mg |
8 | 5mg | - | 10mg | - | - | 0.25mg |
9 | - | 5mg | 20mg | 0.8mg | - | - |
10 | - | 2.5mg | 10mg | 0.4mg | - | - |
11 | - | 5mg | 20mg | - | 1.0mg | - |
12 | - | 2.5mg | 10mg | - | 0.5mg | - |
13 | - | 5mg | 20mg | - | - | 0.75mg |
14 | - | 2.5mg | 10mg | - | - | 0.25mg |
15 | - | 2.5mg | 10mg | - | - | 0.125mg |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101443568A CN1969855B (zh) | 2006-12-04 | 2006-12-04 | 一种具有靶器官保护作用的药物组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101443568A CN1969855B (zh) | 2006-12-04 | 2006-12-04 | 一种具有靶器官保护作用的药物组合物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1969855A CN1969855A (zh) | 2007-05-30 |
CN1969855B true CN1969855B (zh) | 2010-09-01 |
Family
ID=38111004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101443568A Expired - Fee Related CN1969855B (zh) | 2006-12-04 | 2006-12-04 | 一种具有靶器官保护作用的药物组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1969855B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890165A (zh) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | 降压组合物及用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824320A (zh) * | 2005-01-13 | 2006-08-30 | 安徽省生物医学研究所 | 含有钙通道阻滞剂和b族维生素的药物组合物及其用途 |
CN1857726A (zh) * | 2005-04-30 | 2006-11-08 | 石家庄制药集团欧意药业有限公司 | 一种治疗高血压合并高血脂心脑血管疾病的药物组合物 |
-
2006
- 2006-12-04 CN CN2006101443568A patent/CN1969855B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824320A (zh) * | 2005-01-13 | 2006-08-30 | 安徽省生物医学研究所 | 含有钙通道阻滞剂和b族维生素的药物组合物及其用途 |
CN1857726A (zh) * | 2005-04-30 | 2006-11-08 | 石家庄制药集团欧意药业有限公司 | 一种治疗高血压合并高血脂心脑血管疾病的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN1969855A (zh) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100382798C (zh) | 一种含有咖啡酰奎宁酸的药物组合物 | |
CN102670864A (zh) | 治疗心脑血管疾病和糖尿病的抗氧化功能的药物组合物 | |
CN101199848B (zh) | 钙通道阻滞剂/利尿剂/叶酸联用的药物组合物及其用途 | |
CN100571708C (zh) | 一种具有协同作用的药物组合物 | |
CN101406472A (zh) | 阿替洛尔/氨氯地平/叶酸类化合物的药物组合物及其用途 | |
CN101199847B (zh) | At1受体拮抗剂/利尿剂/叶酸联用的药物组合物及其用途 | |
CN101590052A (zh) | 含有钙离子拮抗剂、他汀类降脂药和烟酸的药物组合物及其用途 | |
CN101176788B (zh) | Ace抑制剂/利尿剂/叶酸联用的药物组合物及其用途 | |
CN106310278A (zh) | 一种含叶酸的多联降压药物组合物 | |
CN1969855B (zh) | 一种具有靶器官保护作用的药物组合物及其用途 | |
CN102370965A (zh) | 一种含有左旋氨氯地平药学上可接受的盐与培哚普利药学上可接受的盐的药物组合物 | |
CN101590239B (zh) | 含有利尿剂、他汀和叶酸的药物组合物及其用途 | |
CN101543483B (zh) | 西尼地平胶囊及其制备方法和质量检测方法 | |
CN104224788A (zh) | 吲哒帕胺和叶酸的药物组合物及其用途 | |
CN101590051B (zh) | 含有烟酸、HMG-CoA还原酶抑制剂和α-糖苷酶抑制剂的药物组合物 | |
CN103230594A (zh) | α-葡萄糖苷酶抑制剂和B族维生素的药物组合物 | |
CN101590240B (zh) | 含血管紧张素ⅱ受体拮抗剂、他汀和叶酸的组合物及用途 | |
CN100531729C (zh) | 含有苯氧芳酸类药物和牛磺酸的组合物 | |
CN101422459A (zh) | 阿替洛尔/尼群地平/叶酸类化合物的药物组合物及其用途 | |
CN103272236B (zh) | 含有β-肾上腺素受体阻滞剂和B族维生素的药物组合物及其用途 | |
CN101590232A (zh) | 血管紧张素转化酶抑制剂、他汀类降脂药和烟酸的药物组合物及其用途 | |
CN102631357B (zh) | 一种缬沙坦与氢氯噻嗪药物组合物片剂及其制备方法 | |
CN101897711B (zh) | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 | |
CN102349906B (zh) | 阿托伐他汀钙和烟酸组合物及其制备方法 | |
CN101347434B (zh) | 含有肾素抑制剂与叶酸类化合物的药物组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN AUSA PHARMED LTD. Free format text: FORMER OWNER: HUA'ANFO MEDICINE RESEARCH CENTER CO., LTD., BEIJING Effective date: 20121203 Owner name: SHENZHEN AUSA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ANHUI RESEARCH INSTITUTE OF BIOMEDICINE Effective date: 20121203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Xiping Inventor after: Chen Guangliang Inventor after: Wang Linlin Inventor after: Wang Yan Inventor after: Yu Duo Inventor after: Li Hua Inventor after: Wang Wenyan Inventor after: Chen Mingxia Inventor after: Wang Binyan Inventor before: Xu Xiping Inventor before: Chen Guangliang Inventor before: Wang Linlin Inventor before: Wang Yan Inventor before: Yu Duo Inventor before: Li Hua Inventor before: Wang Wenyan Inventor before: Chen Mingxia |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XU XIPING CHEN GUANGLIANG WANG LINLIN WANG YAN YU DUO LI HUA WANG WENYAN CHEN MINGXIA TO: XU XIPING CHEN GUANGLIANG WANG LINLIN WANG YAN YU DUO LI HUA WANG WENYAN CHEN MINGXIA WANG BINYAN Free format text: CORRECT: ADDRESS; FROM: 100026 CHAOYANG, BEIJING TO: 518057 SHENZHEN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121203 Address after: 518057, No. 16, No. three, No. 3, building No. 1, No. 1, building No. 1, building No. 1, No. 1, building, high tech, Nanshan hi tech Zone, Shenzhen, Guangdong Patentee after: Shenzhen Osa Pharmaceutical Co.,Ltd. Patentee after: SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. Address before: 100026 Beijing city Chaoyang District tianshuiyuan Street No. 6 room 707 Patentee before: Beijng HAFO Biomedical Research Center, Inc. Patentee before: Anhui Biological Medical Institute |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Pharmaceutical composition having target organ protection function and usage thereof Effective date of registration: 20130702 Granted publication date: 20100901 Pledgee: China Everbright Bank Shenzhen Bagualing branch Pledgor: Shenzhen Osa Pharmaceutical Co.,Ltd.|SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. Registration number: 2013990000424 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160705 Granted publication date: 20100901 Pledgee: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgor: Shenzhen Osa Pharmaceutical Co.,Ltd.|SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. Registration number: 2013990000424 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160705 Registration number: 2013990000424 Pledgee after: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgee before: China Everbright Bank Shenzhen Bagualing branch |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100901 Termination date: 20211204 |